The company will use the funds for the global introduction of its robotic retinal imaging, AI and teleophthalmology platform.

The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.

According to Dr. David K. Butler, Epic emeritus CMIO and clinical informatics leader at Calyx Partners, securing buy-in from clinicians and staff, tracking training and budgeting for post-go-live optimization are essential for lasting EHR adoption.

The company is on track to be live in 10 U.S. states by the end of 2025.

Pear Suite's platform will give community health workers tools to identify and tackle social determinants of health challenges like food insecurity.

The acquisition will also extend Ascend's support of the healthcare workforce outside of the classroom.